Implications of therapy-induced selective autophagy on tumor metabolism and survival

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Hughson, Luke R K ^a,b   Poon, Vincent I ^a,b   Spowart, Jaeline E ^a,b   Lum, Julian J ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; 3 METHYLADENINE; BORTEZOMIB; BUTYRIC ACID; CAMPTOTHECIN; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLOROQUINE; CISPLATIN; CURCUMIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; LONIDAMINE; NAVELBINE; PACLITAXEL; PARKIN; PROTEASOME INHIBITOR; SALINOSPORAMIDE A; UBIQUITIN; VANADYL DERIVATIVE; WORTMANNIN;

CANCER CELL; CELL METABOLISM; CELL SURVIVAL; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; MANTLE CELL LYMPHOMA; MITOPHAGY; MULTIPLE MYELOMA; NONHUMAN; NUCLEOPHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SELECTIVE AUTOPHAGY; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84861083651     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/872091     Document Type: Review

References (119)

1. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation Cell 2011 144 5 646 674
2. Bonavida B., Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel (Pubitemid 46842700)
3. Giocanti N., Hennequin C., Balosso J., Mahler M., Favaudon V., DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide Cancer Research 1993 53 9 2105 2111 (Pubitemid 23145734)
4. Richardson P. G., Barlogie B., Berenson J., Singhal S., Jagannath S., Irwin D., Rajkumar S. V., Srkalovic G., Alsina M., Alexanian R., Siegel D., Orlowski R. Z., Kuter D., Limentani S. A., Lee S., Hideshima T., Esseltine D. L., Kauffman M., Adams J., Schenkein D. P., Anderson K. C., A phase 2 study of Bortezomib in relapsed, refractory myeloma The New England Journal of Medicine 2003 348 26 2609 2617 (Pubitemid 36741588)
5. Simons A. L., Ahmad I. M., Mattson D. M., Dornfeld K. J., Spitz D. R., 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells Cancer Research 2007 67 7 3364 3370 (Pubitemid 46724876)
6. Spiegelman S., Sawyer R., Nayak R., Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation Proceedings of the National Academy of Sciences of the United States of America 1980 77 8 4966 4970 (Pubitemid 11236547)
7. Cairns R. A., Papandreou I., Sutphin P. D., Denko N. C., Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy Proceedings of the National Academy of Sciences of the United States of America 2007 104 22 9445 9450 (Pubitemid 47185799)
8. Hernlund E., Ihrlund L. S., Khan O., Ates Y. O., Linder S., Panaretakis T., Shoshan M. C., Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir International Journal of Cancer 2008 123 2 476 483 (Pubitemid 351842036)
9. Mohanti B. K., Rath G. K., Anantha N., Kannan V., Das B. S., Chandramouli B. A. R., Banerjee A. K., Das S., Jena A., Ravichandran R., Sahi U. P., Kumar R., Kapoor N., Kalia V. K., Dwarakanath B. S., Jain V., Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas International Journal of Radiation Oncology Biology Physics 1996 35 1 103 111 (Pubitemid 26137174)
10. DeAngelis L. M., Currie V. E., Kim J. H., Krol G., O'Hehir M. A., Farag F. M., Young C. W., Posner J. B., The combined use of radiation therapy and lonidamine in the treatment of brain metastases Journal of Neuro-Oncology 1989 7 3 241 247 (Pubitemid 19225514)
11. Elmore S. P., Qian T., Grissom S. F., Lemasters J. J., The mitochondrial permeability transition initiates autophagy in rat hepatocytes The FASEB Journal 2001 15 12 2286 2287
12. Park Y. E., Hayashi Y. K., Bonne G., Arimura T., Noguchi S., Nonaka I., Nishino I., Autophagic degradation of nuclear components in mammalian cells Autophagy 2009 5 6 795 804
13. Pankiv S., Clausen T. H., Lamark T., Brech A., Bruun J. A., Outzen H., vervatn A., Bjrky G., Johansen T., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy The Journal of Biological Chemistry 2007 282 33 24131 24145 (Pubitemid 47328003)
14. Klionsky D. J., Baehrecke E. H., Brumell J. H., Chu C. T., Codogno P., Cuervo A. M., Debnath J., Deretic V., Elazar Z., Eskelinen E. L., Finkbeiner S., Fueyo-Margareto J., Gewirtz D., Jttel M., Kroemer G., Levine B., Melia T. J., Mizushima N., Rubinsztein D. C., Simonsen A., Thorburn A., Thumm M., Tooze S. A., A comprehensive glossary of autophagy-related molecules and processes (2nd edition) Autophagy 2011 7 11 1273 1294
15. Jung C. H., Jun C. B., Ro S. H., Kim Y. M., Otto N. M., Cao J., Kundu M., Kim D. H., ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery Molecular Biology of the Cell 2009 20 7 1992 2003
16. Ganley I. G., Lam D. H., Wang J., Ding X., Chen S., Jiang X., ULK1 ATG13 FIP200 complex mediates mTOR signaling and is essential for autophagy The Journal of Biological Chemistry 2009 284 18 12297 12305
17. Hanada T., Noda N. N., Satomi Y., Ichimura Y., Fujioka Y., Takao T., Inagaki F., Ohsumi Y., The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy The Journal of Biological Chemistry 2007 282 52 37298 37302
18. Itakura E., Kishi C., Inoue K., Mizushima N., Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG Molecular Biology of the Cell 2008 19 12 5360 5372
19. Mizushima N., Noda T., Yoshimori T., Tanaka Y., Ishii T., George M. D., Klionsky D. J., Ohsumi M., Ohsumi Y., A protein conjugation system essential for autophagy Nature 1998 395 6700 395 398 (Pubitemid 28450691)
20. Mizushima N., Sugita H., Yoshimori T., Ohsumi Y., A new protein conjugation system in human: the counterpart of the yeast Apg12p conjugation system essential for autophagy The Journal of Biological Chemistry 1998 273 51 33889 33892 (Pubitemid 29008848)
21. Sou Y. S., Waguri S., Iwata J. I., Ueno T., Fujimura T., Hara T., Sawada N., Yamada A., Mizushima N., Uchiyama Y., Kominami E., Tanaka K., Komatsu M., The Atg8 conjugation system is indispensable for proper development of autophagic isolation membranes in mice Molecular Biology of the Cell 2008 19 11 4762 4775
22. Young A. R. J., Chan E. Y. W., Hu X. W., Kchl R., Crawshaw S. G., High S., Halley D. W., Lippincott-Schwartz J., Tooze S. A., Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes Journal of Cell Science 2006 119 18 3888 3900 (Pubitemid 44614440)
23. Mizushima N., Yoshimori T., Ohsumi Y., The role of atg proteins in autophagosome formation Annual Review of Cell and Developmental Biology 2011 27 107 132
24. Weidberg H., Shvets E., Elazar Z., Biogenesis and cargo selectivity of autophagosomes Annual Review of Biochemistry 2011 80 125 156
25. Arstila A. U., Shelburne J. D., Trump B. F., Studies on cellular autophagocytosis. A histochemical study on sequential alterations of mitochondria in the glucagon-induced autophagic vacuoles of rat liver Laboratory Investigation 1972 27 3 317 323
26. Kim I., Rodriguez-Enriquez S., Lemasters J. J., Selective degradation of mitochondria by mitophagy Archives of Biochemistry and Biophysics 2007 462 2 245 253 (Pubitemid 46876640)
27. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C. A., Sou Y. S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M., Hattori N., Tanaka K., PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy Journal of Cell Biology 2010 189 2 211 221
28. Geisler S., Holmstrm K. M., Skujat D., Fiesel F. C., Rothfuss O. C., Kahle P. J., Springer W., PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 Nature Cell Biology 2010 12 2 119 131
29. Ikeda H., Kerppola T. K., Lysosomal localization of ubiquitinated jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate Molecular Biology of the Cell 2008 19 11 4588 4601
30. Tan J. M. M., Wong E. S. P., Kirkpatrick D. S., Pletnikova O., Ko H. S., Tay S. P., Ho M. W. L., Troncoso J., Gygi S. P., Lee M. K., Dawson V. L., Dawson T. M., Lim K. L., Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases Human Molecular Genetics 2008 17 3 431 439
31. Peng J., Schwartz D., Elias J. E., Thoreen C. C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S. P., A proteomics approach to understanding protein ubiquitination Nature Biotechnology 2003 21 8 921 926 (Pubitemid 36936199)
32. Hicke L., Schubert H. L., Hill C. P., Ubiquitin-binding domains Nature Reviews Molecular Cell Biology 2005 6 8 610 621 (Pubitemid 41081265)
33. Seibenhener M. L., Babu J. R., Geetha T., Wong H. C., Krishna N. R., Wooten M. W., Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation Molecular and Cellular Biology 2004 24 18 8055 8068 (Pubitemid 39167456)
34. Shvets E., Abada A., Weidberg H., Elazar Z., Dissecting the involvement of LC3B and GATE-16 in p62 recruitment into autophagosomes Autophagy 2011 7 7 683 688
35. Fujita N., Hayashi-Nishino M., Fukumoto H., Omori H., Yamamoto A., Noda T., Yoshimori T., An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure Molecular Biology of the Cell 2008 19 11 4651 4659
36. Narendra D. P., Kane L. A., Hauser D. N., Fearnley I. M., Youle R. J., p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both Autophagy 2010 6 8 1090 1106
37. Okatsu K., Saisho K., Shimanuki M., Nakada K., Shitara H., Sou Y. S., Kimura M., Sato S., Hattori N., Komatsu M., Tanaka K., Matsuda N., P62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria Genes to Cells 2010 15 8 887 900
38. Ding W. X., Ni H. M., Li M., Liao Y., Chen X., Stolz D. B., Dorn G. W., Yin X. M., Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming The Journal of Biological Chemistry 2010 285 36 27879 27890
39. Rodrguez-Hernndez A., Cordero M. D., Salviati L., Artuch R., Pineda M., Briones P., Izquierdo L. G., Cotn D., Navas P., Snchez-Alczar J. A., Coenzyme Q deficiency triggers mitochondria degradation by mitophagy Autophagy 2009 5 1 19 32
40. van Humbeeck C., Cornelissen T., Hofkens H., Mandemakers W., Gevaert K., de Strooper B., Vandenberghe W., Parkin interacts with ambra1 to induce mitophagy Journal of Neuroscience 2011 31 28 10249 10261
41. Narendra D., Tanaka A., Suen D. F., Youle R. J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy Journal of Cell Biology 2008 183 5 795 803
42. Ligeret H., Barthélémy S., Doulakas G. B., Carrupt P. A., Tillement J. P., Labidalle S., Morin D., Fluoride curcumin derivatives: new mitochondrial uncoupling agents FEBS Letters 2004 569 13 37 42 (Pubitemid 38844589)
43. Galluzzi L., Larochette N., Zamzami N., Kroemer G., Mitochondria as therapeutic targets for cancer chemotherapy Oncogene 2006 25 34 4812 4830 (Pubitemid 44192089)
44. Graham F. L., Whitmore G. F., The effect of-beta-D- arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells Cancer Research 1970 30 11 2627 2635
45. Inagaki A., Nakamura T., Wakisaka G., Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes Cancer Research 1969 29 12 2169 2176
46. Decaudin D., Geley S., Hirsch T., Castedo M., Marchetti P., Macho A., Kofler R., Kroemer G., Bcl-2 and Bcl-X(L) antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents Cancer Research 1997 57 1 62 67 (Pubitemid 27020331)
47. Blumenreich M. S., Chou T. C., Andreeff M., Thymidine as a kinetic and biochemical modulator of 1- -D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia Cancer Research 1984 44 2 825 830 (Pubitemid 14184624)
48. Early A. P., Preisler H. D., Slocum H., Rustum Y. M., A pilot study of high-dose 1- -D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology Cancer Research 1982 42 4 1587 1594 (Pubitemid 12148811)
49. Jan G., Belzacq A. S., Haouzi D., Rouault A., Métivier D., Kroemer G., Brenner C., Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria Cell Death and Differentiation 2002 9 2 179 188 (Pubitemid 34144777)
50. Tang Y., Chen Y., Jiang H., Nie D., Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death Cell Death and Differentiation 2010 18 602 618
51. Miller A. A., Kurschel E., Osieka R., Schmidt C. G., Clinical pharmacology of sodium butyrate in patients with acute leukemia European Journal of Cancer and Clinical Oncology 1987 23 9 1283 1287 (Pubitemid 18006717)
52. Henderson I. C., Allegra J. C., Woodcock T., Wolff S., Bryan S., Cartwright K., Dukart G., Henry D., Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer Journal of Clinical Oncology 1989 7 5 560 571 (Pubitemid 19126791)
53. Wheeler R. H., Ensminger W. D., Thrall J. H., Anderson J. L., High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia Cancer Treatment Reports 1982 66 3 493 498 (Pubitemid 12084941)
54. Kobayashi S., Volden P., Timm D., Mao K., Xu X., Liang Q., Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death The Journal of Biological Chemistry 2010 285 1 793 804
55. Osheroff N., Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide Biochemistry 1989 28 15 6157 6160 (Pubitemid 19202003)
56. Kelsen D., Atiq O. T., Saltz L., Niedzwiecki D., Ginn D., Chapman D., Heelan R., Lightdale C., Vinciguerra V., Brennan M., FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer Journal of Clinical Oncology 1992 10 4 541 548
57. Evans S. R., Krown S. E., Testa M. A., Cooley T. P., Von Roenn J. H., Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study Journal of Clinical Oncology 2002 20 15 3236 3241 (Pubitemid 34831520)
58. Mavroudis D., Papadakis E., Veslemes M., Tsiafaki X., Stavrakakis J., Kouroussis C., Kakolyris S., Bania E., Jordanoglou J., Agelidou M., Vlachonicolis J., Georgoulias V., A multicenter randomized clinical trial comparing paclitaxel-cisplatin- etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer Annals of Oncology 2001 12 4 463 470 (Pubitemid 32472099)
59. Katayama M., Kawaguchi T., Berger M. S., Pieper R. O., DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells Cell Death and Differentiation 2007 14 3 548 558
60. Pelicano H., Martin D. S., Xu R. H., Huang P., Glycolysis inhibition for anticancer treatment Oncogene 2006 25 34 4633 4646 (Pubitemid 44187614)
61. Ravagnan L., Marzo I., Costantini P., Susin S. A., Zamzami N., Petit P. X., Hirsch F., Goulbern M., Poupon M. F., Miccoli L., Xie Z., Reed J. C., Kroemer G., Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore Oncogene 1999 18 16 2537 2546 (Pubitemid 29216676)
62. Long B. H., Fairchild C. R., Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase Cancer Research 1994 54 16 4355 4361 (Pubitemid 24273147)
63. Kidd J. F., Pilkington M. F., Schell M. J., Fogarty K. E., Skepper J. N., Taylor C. W., Thorn P., Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore The Journal of Biological Chemistry 2002 277 8 6504 6510 (Pubitemid 34968448)
64. Miller K., Wang M., Gralow J., Dickler M., Cobleigh M., Perez E. A., Shenkier T., Cella D., Davidson N. E., Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer The New England Journal of Medicine 2007 357 26 2666 2676
65. Hitt R., Lpez-Pousa A., Martnez-Trufero J., Escrig V., Carles J., Rizo A., Isla D., Vega M. E., Mart J. L., Lobo F., Pastor P., Valent V., Beln J., Snchez M. A., Chaib C., Pallarés C., Antn A., Cervantes A., Paz-Ares L., Cortés-Funes H., Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer Journal of Clinical Oncology 2005 23 34 8636 8645 (Pubitemid 46211506)
66. Welles L., Seville M. W., Lietzau J., Pluda J. M., Wyvill K. M., Feuerstein I., Figg W. D., Lush R., Odom J., Wilson W. H., Fajardo M. T., Humphrey R. W., Feigal E., Tuck D., Steinberg S. M., Broder S., Yarchoan R., Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma Journal of Clinical Oncology 1998 16 3 1112 1121 (Pubitemid 28108748)
67. Herbst R. S., Prager D., Hermann R., Fehrenbacher L., Johnson B. E., Sandler A., Kris M. G., Tran H. T., Klein P., Li X., Ramies D., Johnson D. H., Miller V. A., TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer Journal of Clinical Oncology 2005 23 25 5892 5899
68. du Bois A., Lck H. J., Meier W., Adams H. P., Mbus V., Costa S., Bauknecht T., Richter B., Warm M., Schrder W., Olbricht S., Nitz U., Jackisch C., Emons G., Wagner U., Kuhn W., Pfisterer J., von Maillot K., Lange W., Berg D., Schlicht E., Peterseim H., Elling D., ney T., Zimmermann V., Renziehausen K., Rohrmann G., Bach H. J., Mller H., Jger W., Mickan H., Ackermann R. H., Wernicke K., Czygan P. J., Schulze-Tollert J., Becker H. J., Nast J., Kramb P., Krner M., Petru E., Carstensen M., Mller W., Zippel H. H., Hilfrich J., Herchenhein W., Mesrogli M., Schneider A., Deutsch G., Klck F. K., Maurer W., Snter S., Gppinger A., Strigl R., Schuhmann R., Khndel K., Fischer D., Leiner C., Peters F., Niedner W., Peschke K. H., Silz T., Schwrer D., Meinerz W., Kramer D., Richter P., Steichele D. F., Krieger P., Lange M., Beck T., Friese K., Rother D., Heilmann L., Dietel J., Petri E., Meyer-Grohbrgge J., Jovanovic V., Robke K., Merkle E., Gretzlehner G., Hanker J. P., Karg C., Burkert W., Grneberger A., Flachsenberg S., A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer Journal of the National Cancer Institute 2003 95 17 1320 1330 (Pubitemid 37160865)
69. Xi G., Hu X., Wu B., Jiang H., Young C. Y.F., Pang Y., Yuan H., Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells Cancer Letters 2011 307 2 141 148
70. Carré M., André N., Carles G., Borghi H., Brichese L., Briand C., Braguer D., Medicine U. F.R., La U. O., Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel The Journal of Biological Chemistry 2002 277 37 33664 33669
71. Romero A., Rabinovich M. G., Vallejo C. T., Perez J. E., Rodriguez R., Cuevas M. A., Machiavelli M., Lacava J. A., Langhi M., Acuna L. R., Amato S., Barbieri R., Sabatini C., Leone B. A., Vinorelbine as first-line chemotherapy for metastatic breast carcinoma Journal of Clinical Oncology 1994 12 2 336 341 (Pubitemid 24056407)
72. Fossella F. V., DeVore R., Kerr R. N., Crawford J., Natale R. R., Dunphy F., Kalman L., Miller V., Lee J. S., Moore M., Gandara D., Karp D., Vokes E., Kris M., Kim Y., Gamza F., Hammershaimb L., Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens Journal of Clinical Oncology 2000 18 12 2354 2362 (Pubitemid 30415821)
73. Fu X., Pan Y., Wang J., Liu Q., Yang G., Li J., The role of autophagy in human lung cancer cell line A549 induced by Vinorelbine Chinese Journal of Lung Cancer 2008 11 3 345 348 (Pubitemid 351976665)
74. Hertzberg R. P., Caranfa M. J., Hecht S. M., On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex Biochemistry 1989 28 11 4629 4638 (Pubitemid 19151036)
75. Shimada Y., Yoshino M., Wakui A., Nakao I., Futatsuki K., Sakata Y., Kambe M., Taguchi T., Ogawa N., Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer Journal of Clinical Oncology 1993 11 5 909 913 (Pubitemid 23146086)
76. Masuda N., Fukuoka M., Kusunoki Y., Matsui K., Takifuji N., Kudoh S., Negoro S., Nishioka M., Nakagawa K., Takada M., CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer Journal of Clinical Oncology 1992 10 8 1225 1229
77. Wagener D. J. T., Verdonk H. E. R., Dirix L. Y., Catimel G., Siegenthaler P., Buitenhuis M., Mathieu-Boue A., Verweij J., Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study Annals of Oncology 1995 6 2 129 132
78. Bae H., Guan J. L., Suppression of autophagy by FIP200 deletion impairs DNA damage repair and increases cell death upon treatments with anticancer agents Molecular Cancer Research 2011 9 9 1232 1241
79. Fuertes M. A., Castilla J., Alonso C., Pérez J. M., Cisplatin biochemical mechanism of action: from cytotoxity to induction of cell death through interconnections between apoptotic and necrotic pathways Current Medicinal Chemistry 2003 10 3 257 266 (Pubitemid 36131658)
80. Liu D., Yang Y., Liu Q., Wang J., Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells Medical Oncology 2011 28 1 105 111
81. Milani M., Rzymski T., Mellor H. R., Pike L., Bottini A., Generali D., Harris A. L., The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib Cancer Research 2009 69 10 4415 4423
82. Ding W. X., Ni H. M., Gao W., Yoshimori T., Stolz D. B., Ron D., Yin X. M., Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability American Journal of Pathology 2007 171 2 513 524 (Pubitemid 47344684)
83. Ding W. X., Ni H. M., Gao W., Chen X., Jeong H. K., Stolz D. B., Liu J., Yin X. M., Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy Molecular Cancer Therapeutics 2009 8 7 2036 2045
84. Fisher R. I., Bernstein S. H., Kahl B. S., Djulbegovic B., Robertson M. J., De Vos S., Epner E., Krishnan A., Leonard J. P., Lonial S., Stadtmauer E. A., O'Connor O. A., Shi H., Boral A. L., Goy A., Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma Journal of Clinical Oncology 2006 24 30 4867 4874 (Pubitemid 46655613)
85. Richardson P. G., Sonneveld P., Schuster M. W., Irwin D., Stadtmauer E. A., Facon T., Harousseau J. L., Ben-Yehuda D., Lonial S., Goldschmidt H., Reece D., San-Miguel J. F., Bladé J., Boccadoro M., Cavenagh J., Dalton W. S., Boral A. L., Esseltine D. L., Porter J. B., Schenkein D., Anderson K. C., Bortezomib or high-dose dexamethasone for relapsed multiple myeloma The New England Journal of Medicine 2005 352 24 2487 2498 (Pubitemid 41007864)
86. Zhu K., Dunner K., McConkey D. J., Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells Oncogene 2010 29 3 451 462
87. Ruiz S., Krupnik Y., Keating M., Chandra J., Palladino M., McConkey D., The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia Molecular Cancer Therapeutics 2006 5 7 1836 1843 (Pubitemid 44323252)
88. Chauhan D., Singh A., Brahmandam M., Podar K., Hideshima T., Richardson P., Munshi N., Palladino M. A., Andersone K. C., Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma Blood 2008 111 3 1654 1664 (Pubitemid 351213457)
89. Colell A., Ricci J. E., Tait S., Milasta S., Maurer U., Bouchier-Hayes L., Fitzgerald P., Guio-Carrion A., Waterhouse N. J., Li C. W., Mari B., Barbry P., Newmeyer D. D., Beere H. M., Green D. R., GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation Cell 2007 129 5 983 997 (Pubitemid 46813151)
90. Warburg O., On the origin of cancer cells Science 1956 123 3191 309 314
91. Warburg O., Wind F., Negelein E., The metabolism of tumors in the body The Journal of General Physiology 1927 8 519 530
92. Milane L., Duan Z., Amiji M., Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer PLoS ONE 2011 6 9, article e24075
93. Floridi A., Bruno T., Miccadei S., Fanciulli M., Federico A., Paggi M. G., Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant ehrlich ascites tumor cells through modulation of energy metabolism Biochemical Pharmacology 1998 56 7 841 849 (Pubitemid 28458978)
94. Mijaljica D., Prescott M., Devenish R. J., The intricacy of nuclear membrane dynamics during nucleophagy Nucleus 2010 1 3 213 223
95. Kovcs A. L., Réz G., Plfia Z., Kovcs J., Autophagy in the epithelial cells of murine seminal vesicle in vitro: formation of large sheets of nascent isolation membranes, sequestration of the nucleus and inhibition by wortmannin and 3-methyladenine Cell and Tissue Research 2000 302 2 253 261
96. Sit K. H., Paramanantham R., Bay B. H., Chan H. L., Wong K. P., Thong P., Watt F., Sequestration of mitotic (M-phase) chromosomes in autophagosomes: mitotic programmed cell death in human Chang liver cells induced by an OH burst from vanadyl(4) Anatomical Record 1996 245 1 1 8 (Pubitemid 26121558)
97. Sit K. H., Paramanantham R., Bay B. H., Wong K. P., Thong P., Watt F., Induction of vanadium accumulation and nuclear sequestration causing cell suicide in human Chang liver cells Experientia 1996 52 8 778 784 (Pubitemid 126585312)
98. Dawaliby R., Mayer A., Microautophagy of the nucleus coincides with a vacuolar diffusion barrier at nuclear-vacuolar junctions Molecular Biology of the Cell 2010 21 23 4173 4183
99. Roberts P., Moshitch-Moshkovitz S., Kvam E., O'Toole E., Winey M., Goldfarb D. S., Piecemeal microautophagy of nucleus in Saccharomyces cerevisiae Molecular Biology of the Cell 2003 14 1 129 141 (Pubitemid 36106025)
100. Krick R., Muehe Y., Prick T., Bremer S., Schlotterhose P., Eskelinen E. L., Millen J., Goldfarb D. S., Thumm M., Piecemeal microautophagy of the nucleus requires the core macroautophagy genes Molecular Biology of the Cell 2008 19 10 4492 4505
101. de Vos W. H., Houben F., Hoebe R. A., Hennekam R., van Engelen B., Manders E. M. M., Ramaekers F. C. S., Broers J. L. V., Van Oostveldt P., Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins Biochimica et Biophysica Acta 2010 1800 4 448 458
102. Kaufmann S. H., Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note Cancer Research 1989 49 21 5870 5878 (Pubitemid 19274139)
103. Akematsu T., Pearlman R. E., Endoh H., Gigantic macroautophagy in programmed nuclear death of Tetrahymena thermophila Autophagy 2010 6 7 901 911
104. Swietach P., Vaughan-Jones R. D., Harris A. L., Regulation of tumor pH and the role of carbonic anhydrase 9 Cancer and Metastasis Reviews 2007 26 2 299 310 (Pubitemid 47101667)
105. Wittig R., Coy J. F., The role of glucose metabolism and glucose-associated signalling in cancer Perspectives in Medicinal Chemistry 2008 1 64 82
106. Shashidharamurthy R., Koteiche H. A., Dong J., Mchaourab H. S., Mechanism of chaperone function in small heat shock proteins: dissociation of the HSP27 oligomer is required for recognition and binding of destabilized T4 lysozyme The Journal of Biological Chemistry 2005 280 7 5281 5289 (Pubitemid 40280001)
107. Murata S., Minami Y., Minami M., Chiba T., Tanaka K., CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein EMBO Reports 2001 2 12 1133 1138 (Pubitemid 34055961)
108. Jnen S. B., Chaachouay H., Richter-Landsberg C., Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes Glia 2010 58 14 1766 1774
109. Pandey U. B., Nie Z., Batlevi Y., McCray B. A., Ritson G. P., Nedelsky N. B., Schwartz S. L., Diprospero N. A., Knight M. A., Schuldiner O., Padmanabhan R., Hild M., Berry D. L., Garza D., Hubbert C. C., Yao T. P., Baehrecke E. H., Taylor J. P., HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS Nature 2007 447 7146 859 863 (Pubitemid 46920134)
110. Iwata A., Riley B. E., Johnston J. A., Kopito R. R., HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin The Journal of Biological Chemistry 2005 280 48 40282 40292 (Pubitemid 41779165)
111. Olzmann J. A., Li A., Chudaev M. V., Chen J., Perez F. A., Palmiter R. D., Chin L. S., Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6 Journal of Cell Biology 2007 178 6 1025 1038 (Pubitemid 47443324)
112. Moore D. J., Parkin: a multifaceted ubiquitin ligase Biochemical Society Transactions 2006 34 5 749 753 (Pubitemid 44796412)
113. Rouschop K. M. A., van den Beucken T., Dubois L., Niessen H., Bussink J., Savelkouls K., Keulers T., Mujcic H., Landuyt W., Voncken J. W., Lambin P., Van Der Kogel A. J., Koritzinsky M., Wouters B. G., The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 Journal of Clinical Investigation 2010 120 1 127 141
114. Grant S., Enhancing proteotoxic stress as an anticancer strategy Oncotarget 2011 2 4 284 286
115. Haynes C. M., Titus E. A., Cooper A. A., Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death Molecular Cell 2004 15 5 767 776 (Pubitemid 39194906)
116. Dreicer R., Petrylak D., Agus D., Webb I., Roth B., Phase I/II study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer Clinical Cancer Research 2007 13 4 1208 1215 (Pubitemid 46424062)
117. Davies A. M., Chansky K., Lara P. N. Jr., Gumerlock P. H., Crowley J., Albain K. S., Vogel S. J., Gandara D. R., Bortezomib plus gemcitabine/ carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II southwest oncology group study (S0339) Journal of Thoracic Oncology 2009 4 1 87 92
118. Kraft C., Peter M., Hofmann K., Selective autophagy: ubiquitin-mediated recognition and beyond Nature Cell Biology 2010 12 9 836 841
119. Matsumoto S., Yasui H., Mitchell J. B., Krishna M. C., Imaging cycling tumor hypoxia Cancer Research 2010 70 24 10019 10023